Kim A Reiss (Reiss Binder), MD

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-360-0735
Fax: 215-662-4646
BA (Psychology)
Colby College, 2002.
Post BA (Pre-Med)
Johns Hopkins University , 2003.
MD (Medicine)
Penn State College of Medicine , 2008.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Reiss KA, Yu S, Mamtani R, Mehta R, D'Addeo K, Wileyto EP, Taddei TH, Kaplan DE.: Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A retrospective, multi-institutional study. Journal of Clinical Oncology 35(31): 3575-3581, Nov 1 2017.

Baumann BC, Wei J, Plastaras J, Lukens J, Damjanov N, Hoteit M, Hsu C, Levine M, Mondschein J, Nadolski G, Olthoff K, Reiss K, Rosen M, Siegelman E, Metz J, Ben-Josef E.: Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma: high rates of local control with low toxicity. ASTRO Conference 2017, San Diego, CA 99(2S): E137-138, Sep 2017 Notes: "Poster Presentation"

Reiss KA, Rangachari D, Cosgrove D, Wilky B, Donehower R: Growing Pains: A Simulation-Based Curriculum for Improving the Transition to Hematology/Oncology Fellowship. Journal of Cancer Education 32(3): 496-502, Sep 2017.

Reiss KA, Yu S, Judy R, Symecko H, Nathanson, KL, Domchek SM.: Platinum-Based Treatment May Improve Overall Survival in Patients with Advanced Pancreatic Ductal Adenocarcinoma and a Germline BRCA or PALB2 Mutation: a retrospective, cohort study. JCO Precision Medicine Sep 2017 Notes: In press.

Arscott WT, Venigalla S, Nead K, Guttmann D, Shabason J, Lukens J, Plastaras, J, Metz J, O’Hara M, Reiss K, Teitelbaum U, Loaiza-Bonilla A, Ben-Josef E. : Promising Preliminary Outcomes Following Use of Concurrent Nab-Paclitaxel and Radiotherapy - A Novel Regimen for Borderline/Unresectable Pancreatic Cancer. ASTRO Conference 2017, San Diego, CA Sep 2017 Notes: "Poster Presentation"

Mark H. O'Hara, Thomas Benjamin Karasic, Irina Vasilevskaya, Maryann Redlinger, Arturo Loaiza-Bonilla, Ursina R. Teitelbaum, Bruce J. Giantonio, Nevena Damjanov, Kim Anna Reiss, Mark Alan Rosen, Daniel F Heitjan, Andrea B. Troxel, Ravi K. Amaravadi, Peter J. O'Dwyer: Phase II trial of the autophagy inhibitor hydroxychloroquine with FOLFOX and bevacizumab in front line treatment of metastatic colorectal cancer (Abstract # 194680). ASCO 2017 Annual Meeting, Chicago, IL June 2017 Notes: "Poster Presentation"

Kim A. Reiss< MD: A Maintenance Trial for Patients with BRCA or PALB2 Mutations. June 2017.

Black TA, Bhagwat N, Savitch SL, Fan R, Yee SS, Redlinger C, Romeo J, McKenzie L, Stanger BZ, O’Dwyer PJ, O’Hara M, Carpenter EL, Reiss KA.: Development of a highly sensitive digital droplet PCR assay for analysis of circulating tumor DNA in pancreatic adenocarcinoma. University of Pennsylvania Department of Medicine Research Day, Philadelphia, PA May 2017 Notes: "Poster Presentation"

Jacob E. Shabason1, Jerry Chen1, Smith Apisarnthanarax2, Nevena Damjanov3, Bruce Giantonio3, Arturo Loaiza-Bonilla3, Peter O’Dwyer3, Mark O’Hara3, Kim Reiss3, Ursina Teitelbaum3, Paul Wissel3, Jeffery Drebin4, Charles Vollmer4, Michael Kochman5, Rosemarie Mick6, Norge Vergara7, Nirag Jhala8, Abigail Berman1, Jay Dorsey1, Sydney M. Evans1, Gary Kao1, John. N. Lukens1, John P. Plastaras1, James M. Metz1 and Edgar Ben-Josef1.: A Phase I Dose Escalation Trial of Nab-Paclitaxel and Fixed Dose Radiation in Patients with Unresectable or Borderline Resectable Pancreatic Cancer. Association for Clinical and Translational Science Annual Meeting, Washington, DC Apr 2017 Notes: "Poster Presentation"

Reiss KA, Herman JM, Armstrong D, Zahurak M, Fyles A, Brade A, Milosevic M, Dawson LA, Scardina A, Fischer P, Hacker-Prietz A, Kinders RJ, Wang L, Chen A, Temkin S, Horiba N, Stayner LA, Siu LL, Azad NS: A Final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers. Gynecologic Oncology 144(3): 486-490, Mar 2017 Notes:

back to top
Last updated: 12/15/2017
The Trustees of the University of Pennsylvania